April 28, 2004, LaGrange, IL— Cognis Nutrition and Health, a global leader in the manufacture and innovation of nature-based ingredients and application technology for health and food products, announced today that the TONALIN® (Tôn-a-lin) brand of CLA (Conjugated Linoleic Acid) had been self-affirmed as Generally Recognized As Safe (GRAS) by a panel of independent experts. Cognis now offers the food industry one of the most extensive lines of CLA ingredients available for a broad range of approved food applications.
TONALIN®, the #1 consumer brand of CLA, is intended to help consumers lose body fat, maintain lean body mass, prevent fat regain and contribute to improved overall health.
A panel of independent experts has found that TONALIN® is safe for use in yogurt, meal replacement bars and drinks, fruit juices, chocolate, milk-based beverages and coffee cream substitutes. Cognis Nutrition & Health asked this panel to evaluate research conducted with TONALIN® to determine its safety for use in food products.
“TONALIN® is already the most recognized brand of CLA, and now with it achieving self-affirmed GRAS status, it should be the ingredient of choice for food manufacturers wanting to market safe and effective products targeted at consumers to help them improve their body composition,” said Scott Backman, Cognis’ Market Development Manager—Functional Food and Food Technology. “This new ingredient for food could help revolutionize the way people reduce body fat. We expect the high level of consumer awareness for the TONALIN® brand to grow even more as a result of national radio and print advertising campaigns, widespread media coverage, and in-store promotions,” Mr. Backman explained.
Interest in TONALIN® CLA has been spurred by consumers’ increased demand for safe, natural, non-stimulant products for reducing unwanted inches. He pointed out that “sales of TONALIN® CLA products have grown by more than 400 percent since 1997 demonstrating a broad consumer following for this brand of CLA.”
TONALIN® CLA is available as a dietary supplement sold in health food stores, retail chains and pharmacies.
Heather Nelson Cortes, PhD, who heads Cognis’ global science program for TONALIN®, said, “The majority of all published, CLA clinical research has been done with TONALIN® CLA. Seven clinical studies published within the last four years, within peer-reviewed journals, all indicate significant improvement in at least one body composition measurement with TONALIN® CLA.” She explained that TONALIN® CLA has been clinically proven to aid in the maintenance of lean tissue and may help tone the body without necessarily causing overall weight loss. “It is thought to do this in several ways: by decreasing the amount of fat stored after eating, increasing the rate of fat breakdown and metabolism—helping your body use its existing fat for energy—and decreasing the total number of fat cells,” she said.
Cognis produces TONALIN® CLA through a new proprietary process that converts linoleic acid from safflowers into CLA which provides the highest quality of CLA available. TONALIN® CLA contains the lowest amount of non-naturally occurring isomers, a patent-protected attribute that provides food manufacturers with the highest levels of ingredients known to be beneficial. CLA is available in several product forms – oil, water-dispersible powder and emulsions – that offer food manufactures a broad range of options for their new products. In a 2003 July report issued by the FDA titled “Food Labelling: Trans Fatty Acids in Nutrition Labelling, Nutrient Content Claims, and Health Claims,” CLA was specifically referenced as not requiring trans fatty acid labelling.
About TONALIN® CLA:
TONALIN® is the original brand of CLA and is an exclusively licensed product of the Cognis Group. CLA is a polyunsaturated, conjugated fatty acid that is a natural part of the human diet found primarily in meat and dairy products.
For information in North America about TONALIN® brand CLA, please call 800.673.3702 to place an order, e-mail firstname.lastname@example.org, or fax 513.482.3576. For information in Europe, call +49.211.7940.9692, e-mail email@example.com, or fax +49.211.798.2390. For information in Asia Pacific, call +61.3.9584.4588, e-mail firstname.lastname@example.org, or fax +61.3.9584.8348.
Cognis is a worldwide supplier of innovative specialty chemicals and nutritional ingredients. It employs 8,600 people, and has production sites and service centers in almost 30 countries. The company has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Additionally, Cognis provides solutions for a number of other industries, such as coatings and inks, lubricants, textiles and plastics, as well as agriculture and mining. Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and Schroder Ventures Life Sciences. In 2003, Cognis recorded sales of 2.95 billion euros and an operating profit before depreciation, amortization and exceptional items (EBITDA recurring) of 312 million euros.